Atellica CH N-Acetilprocainamida (NAPA)

N-Acetylprocainamide · class III · Until 22/04/2036

Registration no.
10345162557
Process no.
25351012640202651
Status
Until 22/04/2036
Device type
N-Acetylprocainamide (N-ACETILPROCAINAMIDA)
Risk class
III
Registration holder
SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA CNPJ 01.449.930/0001-90 · 2,590 registrations
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC. · United States
Published
22/04/2026
Valid until
22/04/2036
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗